Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Alcon Research | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Safety and efficacy of antibiotic steroid combination compared with individual administration in the treatment of bacterial ocular inflammation and infection (blepharitis and/or keratitis and/or conjunctivitis).
Antibiotic/steroid combination compared to individuals components 8 days of treatment.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 2 | Active Comparator | antibiotic /steroid combination compared with individual administration of steroid and antibiotic |
|
| 1 | Experimental | combination antibiotic steroid compared with individual administration of steroid and antibiotic - new therapeutic indication |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Moxifloxacin and Dexamethasone combined | Drug | moxifloxacin 0,5% qid and dexamethasone 0,1% qid combined |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of ocular sign/symptoms (hyperemia on bulbar conjunctiva, palpebral conjunctiva, conjunctival exsudates, palpebral erythema at final visit (Day 8) | Day 8 |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of sign and symptoms of blepharitis and/or keratitis and/or bacterial conjunctivitis | Day 8 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rubens Belfort, MD | Federal University of São Paulo | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Federal University of Sao Paulo | São Paulo | São Paulo | 04040002 | Brazil |
Not provided
Not provided
Not provided
Not provided
Not provided
| Moxifloxacin | Drug | moxifloxacin 0,5% qid and |
|
|
| Dexamethasone | Drug | dexamethasone 0,1% qid |
|
| ID | Term |
|---|---|
| D001762 | Blepharitis |
| D003231 | Conjunctivitis |
| D007634 | Keratitis |
| D015817 | Eye Infections |
| ID | Term |
|---|---|
| D005141 | Eyelid Diseases |
| D005128 | Eye Diseases |
| D003229 | Conjunctival Diseases |
| D003316 | Corneal Diseases |
| D007239 | Infections |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077266 | Moxifloxacin |
| D003907 | Dexamethasone |
| ID | Term |
|---|---|
| D024841 | Fluoroquinolones |
| D042462 | 4-Quinolones |
| D015363 | Quinolones |
| D011804 | Quinolines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |
Not provided
Not provided